Who are ViroXis Corporation, Inc.'s investors?

ViroXis Corporation, Inc.'s investors include Targeted Technology Funds.

How much funding has ViroXis Corporation, Inc. raised?

ViroXis Corporation, Inc. has disclosed $1M raised across 1 round.

ViroXis Corporation, Inc. was acquired by TFS.

ViroXis Corporation, Inc. is headquartered in San Antonio, US.

acquired by TFS

San Antonio, US · 1 known investors

Mid-stage drug developer of botanical anti-viral topical prescription candidates for skin diseases; acquired by TFS Corporation in 2017.

Alan DeanBoard directorSenior Managing Partner at Targeted Technology Funds

Ian William David ClementsBoard directorManaging Partner at Targeted Technology Funds

Paul Castella inBoard directorSenior Managing Partner at Targeted Technology Funds

Gary FrashierBoard director

Form D private placements

$1M disclosed across 1 round · 2012

▶$1MraisedMar 2012 · 6 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does ViroXis Corporation, Inc. do?: Mid-stage drug developer of botanical anti-viral topical prescription candidates for skin diseases; acquired by TFS Corporation in 2017.
Who are ViroXis Corporation, Inc.'s investors?: ViroXis Corporation, Inc.'s investors include Targeted Technology Funds.
How much funding has ViroXis Corporation, Inc. raised?: ViroXis Corporation, Inc. has disclosed $1M raised across 1 round.
Who acquired ViroXis Corporation, Inc.?: ViroXis Corporation, Inc. was acquired by TFS.
Where is ViroXis Corporation, Inc. headquartered?: ViroXis Corporation, Inc. is headquartered in San Antonio, US.